Similarly, M2-TAMs are greatly increased in the tumor tissues of patients with immunoresistant LUAD and enhance the expression of METTL3 and total m6A RNA level, while interfering with METTL3 could significantly reverse immunoresistance (33). The gene discussed is METTL3; the disease is neoplasm.